GlassScriptPhysician profile
Zachary David Ranly
NPI 1831649409
$2,503.63
in general payments reported to CMS, 2019-2025
11 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $227 · 2022: $308 · 2023: $566 · 2024: $860 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,968.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,769.81 | 2021-2025 | Persona, Genex, Avitus Bone Harvester |
| Depuy Synthes Sales INC. | $260.21 | 2021-2025 | Attune |
| Kci USA, INC. | $165.74 | 2021-2023 | Prevena Restor Arthroform, Prevena |
| Solventum Corporation | $109.14 | 2024-2025 | Prevena, V.A.C.Instill, Prevena Restor Arthroform |
| Innovation Technologies INC | $51.68 | 2024-2025 | Irrisept |
| Stryker Corporation | $43.11 | 2024-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $35.57 | 2024 | Journey II |
| Ethicon US, LLC | $20.13 | 2025 | Vistaseal, Ethicon |
| Heron Therapeutics, INC. | $19.29 | 2025 | Zynrelef |
| Biocomposites INC | $14.80 | 2025 | Stimulan |
| Tela Bio, INC. | $14.15 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Ranly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.